Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34547915)
Watch
English
Treatment of chronic hepatitis B.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Treatment of chronic hepatitis B
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
main subject
chronic hepatitis
1 reference
based on heuristic
inferred from title
author
Ching-Lung Lai
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
author name string
M F Yuen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
publication date
1 November 2001
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
published in
Lancet Infectious Diseases
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
volume
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
issue
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
page(s)
232-241
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
cites work
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of chronic hepatitis B with interferon: experience in western countries
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of chronic hepatitis B with interferon: experience in Asian patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transmission of HBsAg from mother to infant in four ethnic groups
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term remission of chronic hepatitis B after alpha-interferon therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacokinetics of lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Profound suppression of hepatitis B virus replication with lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine as initial treatment for chronic hepatitis B in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral dynamics in hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatitis B: 2000--summary of a workshop
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral L-nucleosides specific for hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy for hepatitis B virus: the final solution?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900118-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1473-3099(01)00118-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
PubMed publication ID
11871510
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11871510
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11871510%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit